The immune microenvironment in hodgkin lymphoma: T cells, B cells, and immune checkpoints Journal Article


Authors: Vardhana, S.; Younes, A.
Article Title: The immune microenvironment in hodgkin lymphoma: T cells, B cells, and immune checkpoints
Abstract: Classical Hodgkin lymphoma is curable in the majority of cases with chemotherapy and/or radiation. However, 15-20% of patients ultimately relapse and succumb to their disease. Pathologically, classical Hodgkin lymphoma is characterized by rare tumor-initiating Reed-Sternberg cells surrounded by a dense immune microenvironment. However, the role of the immune microenvironment, particularly T and B cells, in either promoting or restricting Classical Hodgkin lymphoma growth remains undefined. Recent dramatic clinical responses seen using monoclonal antibodies against PD-1, a cell surface receptor whose primary function is to restrict T cell activation, have reignited questions regarding the function of the adaptive immune system in classical Hodgkin lymphoma. This review summarizes what is known regarding T cells, B cells, and immune checkpoints in classical Hodgkin lymphoma. © 2016 Ferrata Storti Foundation.
Journal Title: Haematologica
Volume: 101
Issue: 7
ISSN: 0390-6078
Publisher: Ferrata Storti Foundation  
Date Published: 2016-07-01
Start Page: 794
End Page: 802
Language: English
DOI: 10.3324/haematol.2015.132761
PROVIDER: scopus
PUBMED: 27365459
PMCID: PMC5004458
DOI/URL:
Notes: Review -- Export Date: 2 August 2016 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Anas Younes
    319 Younes
  2. Santosha Adipudi Vardhana
    102 Vardhana